BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 22938157)

  • 21. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
    Menter A; Abramovits W; Colón LE; Johnson LA; Gottschalk RW
    J Drugs Dermatol; 2009 Jan; 8(1):52-7. PubMed ID: 19180896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate compared with commonly used topical treatments in the management of moderately severe plaque psoriasis in Scotland.
    Bottomley JM; Auland ME; Morais J; Boyd G; Douglas WS
    Curr Med Res Opin; 2007 Aug; 23(8):1887-901. PubMed ID: 17610804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acrodermatitis continua of Hallopeau on toes successfully treated with a two-compound product containing calcipotriol and betamethasone dipropionate.
    Sotiriadis D; Patsatsi A; Sotiriou E; Sotiriou E; Papagaryfallou I; Chrysomallis F
    J Dermatolog Treat; 2007; 18(5):315-8. PubMed ID: 17852633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The separate daily application of tacalcitol 4 µg/g ointment and budesonide 0.25 mg/g cream is more effective than the single daily application of a two compound ointment containing calcipotriol 50 µg/g and betamethasone dipropionate 0.5 mg/g.
    Calzavara-Pinton P; Rossi MT; Sala R; Venturini M
    G Ital Dermatol Venereol; 2011 Aug; 146(4):295-9. PubMed ID: 21785396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Double-blind, right/left comparison of calcipotriol ointment and betamethasone ointment in the treatment of Prurigo nodularis.
    Wong SS; Goh CL
    Arch Dermatol; 2000 Jun; 136(6):807-8. PubMed ID: 10871962
    [No Abstract]   [Full Text] [Related]  

  • 26. Microcirculatory modifications of psoriatic lesions during topical therapy.
    Rosina P; Giovannini A; Gisondi P; Girolomoni G
    Skin Res Technol; 2009 May; 15(2):135-8. PubMed ID: 19622121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In touch with psoriasis: topical treatments and current guidelines.
    Murphy G; Reich K
    J Eur Acad Dermatol Venereol; 2011 Jun; 25 Suppl 4():3-8. PubMed ID: 21507077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluating the efficacy and safety of calcipotriene/betamethasone ointment occluded with a hydrogel patch: a 6-week bilaterally controlled, investigator-blinded trial.
    Patel T; Bhutani T; Busse KL; Koo J
    Cutis; 2011 Sep; 88(3):149-54. PubMed ID: 22017069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcipotriol: clinical trial versus betamethasone dipropionate + salicylic acid.
    Scarpa C
    Acta Derm Venereol Suppl (Stockh); 1994; 186():47. PubMed ID: 8073835
    [No Abstract]   [Full Text] [Related]  

  • 30. Calcipotriol-betamethasone ointment versus calcipotriol ointment in the treatment of psoriasis vulgaris.
    Duweb G; Alhaddar J; Elsherif B; Eljehawi N; Makhlouf H
    Drugs Exp Clin Res; 2005; 31(5-6):175-9. PubMed ID: 16425973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness model of topical treatment of mild to moderate psoriasis vulgaris in Germany. A comparison of calcipotriol/betamethasone (Daivobet/Dovobet/Taclonex) once daily and a morning/evening non-fix combination of calcipotriol and betamethasone.
    Augustin M; Peeters P; Radtke M; Moehling U; Lapp C
    Dermatology; 2007; 215(3):219-28. PubMed ID: 17823519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
    de Korte J; van der Valk PG; Sprangers MA; Damstra RJ; Kunkeler AC; Lijnen RL; Oranje AP; de Rie MA; de Waard-van der Spek FB; Hol CW; van de Kerkhof PC
    Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The atrophogenic potential and dermal tolerance of calcipotriol/betamethasone dipropionate ointment compared with betamethasone dipropionate ointment.
    Traulsen J; Hughes-Formella BJ
    Dermatology; 2003; 207(2):166-72. PubMed ID: 12920367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet) versus calcipotriol (Daivonex) in the treatment of psoriasis vulgaris: a randomized, multicentre, clinical trial.
    Saraceno R; Andreassi L; Ayala F; Bongiorno MR; Giannetti A; Lisi P; Martini P; Peris K; Peserico A; Chimenti S
    J Dermatolog Treat; 2007; 18(6):361-5. PubMed ID: 17934937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The calcipotriol-betamethasone dipropionate association].
    Henry F; Flagothier C; Delvoye P; Piérard-Franchimont C; Piérard GE
    Rev Med Liege; 2005 Nov; 60(11):893-5. PubMed ID: 16402537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of guttate psoriasis with a new two-compound product containing calcipotriol and betamethasone dipropionate.
    Vakirlis E; Kastanis A; Lazaridou E; Loannides D; Chrysomallis F
    Int J Clin Pharmacol Res; 2005; 25(4):165-8. PubMed ID: 16402632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcipotriol and betamethasone dipropionate (Dovobet, Daivobet): a new formulation for the treatment of psoriasis.
    Poulin Y
    Skin Therapy Lett; 2002 Jun; 7(6):1-3. PubMed ID: 12223976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical therapy for psoriasis with the use of augmented betamethasone and calcipotriene on alternate weeks.
    Singh S; Reddy DC; Pandey SS
    J Am Acad Dermatol; 2000 Jul; 43(1 Pt 1):61-5. PubMed ID: 10863225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The two-compound formulation of calcipotriol and betamethasone dipropionate for treatment of moderately severe body and scalp psoriasis - an introduction.
    Freeman K
    Curr Med Res Opin; 2011 Jan; 27(1):197-203. PubMed ID: 21142834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial.
    Kragballe K; Hoffmann V; Ortonne JP; Tan J; Nordin P; Segaert S
    Br J Dermatol; 2009 Jul; 161(1):159-66. PubMed ID: 19416259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.